Form 13F-NT - Quarterly report filed by institutional managers, Notice:
SEC Accession No. 0001172661-19-002357
Filing Date
2019-11-14
Accepted
2019-11-14 16:10:06
Documents
1
Period of Report
2019-09-30
Effectiveness Date
2019-11-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-NT  
1 primary_doc.xml 13F-NT 2180
  Complete submission text file 0001172661-19-002357.txt   3264
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED CAPITAL LLC (Filer) CIK: 0001157524 (see all company filings)

EIN.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 13F-NT | Act: 34 | File No.: 028-10410 | Film No.: 191220183